Sparc Life
Priyanka Sahu currently serves as a Research Associate at Sun Pharma Advanced Research Company Ltd. and SUN PHARMA, roles held since March 2019. Prior to this, Priyanka gained experience as a Research Intern at Wockhardt Ltd. from May 2018 to February 2019 and worked as a Junior Research Fellow at ITM University from December 2016 to May 2017. Priyanka holds an M.Tech in Biotechnology from Madhav Institute of Technology and Science, Gwalior, obtained between 2014 and 2016, and completed BITP training in Research and Development at Biotech Consortium India Limited in 2018. Additionally, Priyanka earned a B.Tech in Biotechnology from Bundelkhand University.
Sparc Life
SPARC (NSE: SPARC; BSE: 532872) is a biopharmaceutical company continuously innovating new therapies in oncology, neurodegeneration, and immunology. SPARC's value proposition lies in our brick-and-mortar infrastructure to effectively translate therapies from the bench, through clinical studies, to regulatory approval. This engine has resulted in approval of two NDAs. Our approved products are marketed by our commercial partners in the US, China, and India. We are 400+ strong team spread across three global locations, with a vibrant research community of 350+ scientists working on a robust pipeline of clinical and preclinical programs. Our teams' strengths span the R&D spectrum: small and large molecule drug discovery; CMC development; preclinical translation (including NDA-enabling toxicology); and clinical development and operations. All of this makes SPARC unique among other small biopharma companies, especially single-asset or single-therapy focused companies. We continue to build and strengthen our innovation engine with emphases on strong scientific execution, high value analytics, and aggressive portfolio management, to redefine patient care in areas of unmet need.